Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Just Biotherapeutics, Inc.

http://www.justbiotherapeutics.com/

Latest From Just Biotherapeutics, Inc.

Evotec Stock Buoyed By Takeda Alliance

Evotec and Takeda aim to develop at least five drug candidates by leveraging the German group’s discovery platform.

Companies Deals

Evotec Had Strong H1, Foresees Dual Track Growth After Entering Biologics Space

Evotec upped its full-year guidance after a strong second quarter that saw an important strategic expansion into the biologics space through the acquisition of Just Biotherapeutics Inc.

Commercial Companies

Deal Watch: Ireland's Amryt Acquires Aegerion

European firms Amryt and Evotec have signed agreements to acquire two companies based across the Atlantic – Aegerion and Just Biotherapeutics, respectively. 

Deals M & A

Venture Funding Deals: I-Mab Is The Mega-Round Leader With $220m Series C

Freeline Therapeutics, I-Mab Biopharma, Kaleido Biosciences and Precision BioSciences raised more than $100m each, but Chinese start-ups continue to bring in some of this year's largest venture capital mega rounds, with $220m in Series C cash to fund development of immuno-oncology and inflammatory disease drug candidates.

Financing StartUps and SMEs
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Hangzhou Just Biotherapeutics, Ltd.
    • Just.Bio
UsernamePublicRestriction

Register